preclinical
The Promise of Nanomedicine
The Promise of Nanomedicine
Jef Akst | Apr 8, 2014
At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.
Opinion: Translational Biotechnology
Opinion: Translational Biotechnology
John D. Loike and Jennifer E. Miller | Feb 17, 2014
Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.
Report Card: Sharing Animal Research
Report Card: Sharing Animal Research
Tracy Vence | Jan 8, 2014
New analysis finds that funding agencies, scientists, and journals are not including sufficient information when reporting on in vivo experiments.
Opinion: Translational Research in Crisis
Opinion: Translational Research in Crisis
Masoud H. Manjili | Sep 10, 2013
Turning discoveries made in academic labs into innovative therapies requires a radically new approach.
Obesity-Fighting Drug May Improve Metabolism
Obesity-Fighting Drug May Improve Metabolism
Erin Weeks | Sep 3, 2013
Initial tests of a hormone therapy suggest it reduces LDL cholesterol and improves weight loss in obese patients with type 2 diabetes.
Week in Review, July 15–19
Week in Review, July 15–19
Jef Akst | Jul 19, 2013
Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation
Release of Drug Data Blocked
Release of Drug Data Blocked
Dan Cossins | May 2, 2013
A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
Science’s Reproducibility Problem
Science’s Reproducibility Problem
Bob Grant | Dec 18, 2012
A recent roundtable discussion identifies challenges facing the scientific community regarding a lack of reproducible results in the literature.
Translational Training for PhDs
Jef Akst | Jul 10, 2012
The National Institutes of Health is launching a pilot program to introduce students to clinical and translational research.
Bioterrorist Battles
Fran Hawthorne | Jan 1, 2012
A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.